We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Clinical Data on New Assay Panel Demonstrates Accurate Assessment of Pancreatic Cancer Risk

By LabMedica International staff writers
Posted on 31 Jul 2025

Pancreatic cancer is the third-deadliest cancer in the US. More...

Early detection is key to improving the survival rate. One window to early diagnosis is pancreatic cystic lesions (PCL), a known precursor lesion for pancreatic cancer. Patients diagnosed with pancreatic cysts are at higher risk of pancreatic cancer, but many of these cystic lesions are benign, so risk stratification tools are critical. Now, new clinical validation data presented at ADLM 2025 highlights recent findings related to the stratification of PCLs, a complex and increasingly common clinical challenge.

The work builds on PanCystPro, a CLIA-cleared assay from Amplified Sciences (West Lafayette, IN, USA), which is designed to assist clinicians in the risk stratification of patients diagnosed with PCL by distinguishing between mucinous and non-mucinous cysts using comparatively less fluid. The PanCystPro test uses a proprietary platform that enables ultrasensitive detection of multiple biomarkers in small volumes of pancreatic cyst fluid. This multianalyte assay utilizes a robust algorithm and features a novel protease activity assay, enabling better biological insight to inform risk stratification of PCL. This multianalyte assay utilizes a robust algorithm and features a novel protease activity assay, enabling better biological insight to inform risk stratification of PCL.

This highly accurate test allows clinicians to define low-risk and/or benign pancreatic cysts, ruling out potential for malignancy, thus resulting in significant cost savings and patient peace of mind. In testing among several clinical cohorts, the assay provides the advantages of increased accuracy, high negative predictive value, a robust panel of biomarkers including the measurement of important protease activity, and a significantly reduced volume of pancreatic cyst fluid required. This test will address the need of gastroenterologists, pancreatic biliary surgeons, and other clinicians for better diagnostic tests to manage patients diagnosed with pancreatic cysts. At ADLM 2025, Mini Thomas, PhD, Principal Scientist, is highlighting recent findings related to the stratification of PCLs.

“The data show high accuracy and predictive value in grading dysplasia in pancreatic cystic lesions—a key risk factor for pancreatic cancer. These results highlight the potential of our diagnostic platform BioMatra and support the assay panel’s ability to reliably classify dysplasia in high-risk lesions, such as Intraductal Papillary Mucinous Neoplasms (IPMNs),” said Diana Caldwell, CEO of Amplified Sciences. “With minimal sample volume requirements, this approach will support earlier risk stratification, an important step given that nearly 80% of pancreatic cancer cases are diagnosed at a late stage.”

Related Links:
Amplified Sciences


New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: Automated cell imaging discriminates CD8+ T cells according to natalizumab treatment outcome in MS patients (B Chaves et al., Nat Commun 16, 5533 (2025). DOI: 10.1038/s41467-025-60224-3)

Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients

Multiple sclerosis (MS) is a chronic autoimmune and degenerative neurological disease that affects the central nervous system, leading to motor, cognitive, and mental impairments. Symptoms can include... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: ELITechGroup’s unique Real-Time PCR technologies include the revolutionary Minor Groove Binder (Photo courtesy of ELITechGroup)

ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. The use of PCR during the COVID-19 pandemic showed its value, but traditional systems... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.